Eye Meds Now

 Quick Ophthalmic Drug Search

224 items found
ZYLET (loteprednol etabonate (0.5%) – tobramycin (0.3%) ophthalmic suspension)
Prescription
Topical
Ophthalmic Suspension
Antibiotic–Steroid Combination Medications
Indications/Usage:

Indicated for use as a topical anti-infective and corticosteroid combination for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists.

Ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, and where the inherent risk of steroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. They are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns, or penetration of foreign bodies.

The use of a combination drug with an anti-infective component is indicated where the risk of superficial ocular infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye.

The particular anti-infective drug in this product (tobramycin) is active against the following common bacterial eye pathogens: Staphylococci, including S. aureus and S. epidermidis (coagulase-positive and coagulasenegative), including penicillin-resistant strains. Streptococci, including some of the Group Abeta-hemolytic species, some nonhemolytic species, and some Streptococcus pneumoniae, Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, Enterobacter aerogenes, Proteus mirabilis, Morganella morganii, most Proteus vulgaris strains, Haemophilus influenzae, and H. aegyptius, Moraxella lacunata, Acinetobacter calcoaceticus and some Neisseria species.

This medication has a broad FDA approval for "inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe." We have linked this medication with conditions we understand to be categorized as "inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe." This is our medical opinion and may not be true in all clinical circumstances.

Typical Dosing:  

Steroid-responsive inflammatory ocular conditions, recommended:

  • Apply 1 – 2 drops of ZYLET® into the conjunctival sac of the affected eye every 4 – 6 hours. During the initial 24 – 48 hours, the dosing may be increased, to every 1 – 2 hours.
  • Frequency should be decreased gradually as warranted by improvement in clinical signs.
  • Care should be taken not to discontinue therapy prematurely.
  • Not more than 20 mL should be prescribed initially and the prescription should not be refilled without further evaluation [See Warnings and Precautions (5.3) in package insert].

How Supplied:  
  • 2.5 mL bottles
  • 5 mL bottles
  • 10 mL bottles

Preservatives:  

benzalkonium chloride


Storage:  
  • Store upright at 59º – 77ºF (15º – 25ºC).
  • Protect from freezing.
  • Shake vigorously before using.


Assistance: Payment Assistance

ZYMAXID (gatifloxacin (0.5%) ophthalmic solution)
Prescription
Topical
Ophthalmic Solution
Antibiotics
Indications/Usage:

Indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Aerobic gram-positive bacteria: Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus mitis group*; Streptococcus oralis*; Streptococcus pneumoniae. Aerobic gram-negative bacteria: Haemophilus influenzae.

*Efficacy for this organism was studied in fewer than 10 infections.


Typical Dosing:  

►Bacterial conjunctivitis caused by susceptible strains of listed organisms:

  •  Patients  1 year of age: 
    • Instill 1 drop every 2 hours in the affected eye(s) while awake, up to 8 times on day 1.
    • Instill 1 drop 2 – 4 times daily in the affected eye(s) while awake on days 2 – 7.

How Supplied:  
  • 2.5 mL bottles

Preservatives:  

benzalkonium chloride


Storage:  
  • Store at 59° – 77°F (15° – 25°C).
  • Protect from freezing.


Assistance: Payment Assistance

ZYRTEC (cetirizine hydrochloride (10 mg) capsules, liquid filled; (10 mg) tablets, orally disintegrating; (10 mg) tablets)
Over the Counter
Oral
Capsules
Oral Disintegrating Tablets
Tablets
Antihistamines
Indications/Usage:

Used for the temporary relief of the following symptoms due to hay fever or other upper respiratory allergies: runny nose; sneezing; itchy, watery eyes; itching of the nose or throat.


Typical Dosing:  

►Runny nose; sneezing; itchy, watery eyes; itching of the nose or throat:

  • Adults and children 6 years of age:
    • One 10 mg capsule or tablet once a day.
    • A 5 mg product may be appropriate for less severe symptoms.
    • Do not take more than one 10 mg capsule or tablet in 24 hours.
    • Orally disintegrating tablet melts in mouth. Can be taken with or without water.
  • Adults  65 years of age:
    • Ask a doctor.
  • Children < 6 years of age: 
    • Ask a doctor.
  • Individuals with liver or kidney disease:
    • Ask a doctor.

How Supplied:  
  • Capsules:
    • 10 mg capsules
  • Tablets, orally disintegrating:
    • 10 mg orally disintegrating tablets
  • Tablets:
    • 10 mg tablets

Preservatives:  

None listed in package insert.


Storage:  
  • Store at 68° – 77°F (20° – 25°C).
  • Avoid high humidity and excessive heat above 104°F (40°C).
  • Protect from light.


ZYRTEC CHILDREN'S (cetirizine hydrochloride (5 mg/5 mL) oral solution; (10 mg) tablets, orally disintegrating)
Over the Counter
Oral
Oral Disintegrating Tablets
Oral Solution
Antihistamines
Indications/Usage:

Used for the temporary relief of the following symptoms due to hay fever or other upper respiratory allergies: runny nose; sneezing; itchy, watery eyes; itching of the nose or throat.


Typical Dosing:  

►Runny nose; sneezing; itchy, watery eyes; itching of the nose or throat:

  • Tablets, orally disintegrating:
    • Adults and children 6 years of age:
      • One 10 mg tablet once a day.
      • A 5 mg product may be appropriate for less severe symptoms.
      • Do not take more than one 10 mg tablet in 24 hours.
      • Orally disintegrating tablet melts in mouth. Can be taken with or without water.
    • Adults  65 years of age:
      • Ask a doctor.
    • Children 6 years of age: 
      • Ask a doctor.
    • Individuals with liver or kidney disease:
      • Ask a doctor.
  • Oral solution:
    • Adults and children 6 years of age:
      • 5 mL or 10 mL once a day depending upon severity of symptoms.
      • Do not take more than 10 mL in 24 hours.
    • Adults  65 years of age:
      • 5 mL once a day.
      • Do not take more than 5 mL in 24 hours.
    • Children 2 to 6 years of age: 
      • 2.5 mL once daily. If needed, dose can be increased to a maximum of 5 mL once daily or 2.5 mL every 12 hours.
      • Do not give more than 5 mL in 24 hours.
    • Children 2 years of age: 
      • Ask a doctor.
    • Individuals with liver or kidney disease:
      • Ask a doctor.
    • Use only with enclosed dosing cup.

How Supplied:  
  • Oral solution:
    • 5 mg/5 mL oral solution
  • Tablets, orally disintegrating:
    • 10 mg orally disintegrating tablets

Preservatives:  

None listed in package insert (tablets); sodium benzoate (oral solution)


Storage:  
  • Store at 68° – 77°F (20° – 25°C).
  • Avoid high humidity and excessive heat above 104°F (40°C).
  • Protect from light.


224 items found